Rare Classroom: Tardive Dyskinesia

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Tardive Dyskinesia

Upstaza for AADC Deficiency Approved by EC

  For months, those within the rare disease community have been watching to see whether Upstaza (eladocagene exuparvovec) would be approved for use within the European Union. In fact, in…

Continue Reading Upstaza for AADC Deficiency Approved by EC